Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. It serves as a building block in the preparation of active pharmaceutical ingredients (APIs) that modulate signaling pathways involved in tumor growth and inflammation. Its structure allows for selective modification, enabling optimization of drug potency, selectivity, and metabolic stability. Commonly employed in research and development within oncology and inflammatory disease programs.